相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Posttranslational regulation of mitochondrial frataxin and identification of compounds that increase frataxin levels in Friedreich's ataxia
Peter T. Hackett et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2022)
Cur@SF NPs alleviate Friedreich's ataxia in a mouse model through synergistic iron chelation and antioxidation
Li Xu et al.
JOURNAL OF NANOBIOTECHNOLOGY (2022)
Nanoparticles in peripheral nerve regeneration: A mini review
Rabia Javed et al.
JOURNAL OF NEURORESTORATOLOGY (2022)
Nanoparticle Toxicology
Wen Yang et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 61, 2021 (2021)
Cationic Carbosilane Dendrimers Prevent Abnormal α-Synuclein Accumulation in Parkinson's Disease Patient-Specific Dopamine Neurons
Raquel Ferrer-Lorente et al.
BIOMACROMOLECULES (2021)
Engineering precision nanoparticles for drug delivery
Michael J. Mitchell et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?
Fangda Leng et al.
NATURE REVIEWS NEUROLOGY (2021)
Nanoemulsion Improves the Neuroprotective Effects of Curcumin in an Experimental Model of Parkinson's Disease
Osmar Vieira Ramires Junior et al.
NEUROTOXICITY RESEARCH (2021)
Treatment with ROS detoxifying gold quantum clusters alleviates the functional decline in a mouse model of Friedreich ataxia
Chiara Villa et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
The potential renal toxicity of silver nanoparticles after repeated oral exposure and its underlying mechanisms
Hamed Nosrati et al.
BMC NEPHROLOGY (2021)
Liposomes loaded with polyphenol-rich grape pomace extracts protect from neurodegeneration in a rotenone-based in vitro model of Parkinson's disease
Attilio Marino et al.
BIOMATERIALS SCIENCE (2021)
Gold Nanoparticles Treatment Reverses Brain Damage in Alzheimer's Disease Model
Natalia dos Santos Tramontin et al.
MOLECULAR NEUROBIOLOGY (2020)
Highly stabilized nanocrystals delivering Ginkgolide B in protecting against the Parkinson's disease
Yao Liu et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
The global burden of neurological disorders: translating evidence into policy
Valery L. Feigin et al.
LANCET NEUROLOGY (2020)
Combined Therapy for Alzheimer's Disease: Tacrine and PAMAM Dendrimers Co-Administration Reduces the Side Effects of the Drug without Modifying its Activity
Daniela E. Igartua et al.
AAPS PHARMSCITECH (2020)
Nanocatalytic activity of clean-surfaced, faceted nanocrystalline gold enhances remyelination in animal models of multiple sclerosis
Andrew P. Robinson et al.
SCIENTIFIC REPORTS (2020)
Role of Rutin Nanoemulsion in Ameliorating Oxidative Stress: Pharmacokinetic and Pharmacodynamics Studies
Shrestha Sharma et al.
CHEMISTRY AND PHYSICS OF LIPIDS (2020)
Immunological and Toxicological Considerations for the Design of Liposomes
Collin T. Inglut et al.
NANOMATERIALS (2020)
The blood-brain barrier in health and disease: Important unanswered questions
Caterina P. Profaci et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Stealth Coating of Nanoparticles in Drug-Delivery Systems
See Yee Fam et al.
NANOMATERIALS (2020)
Endocytosis: The Nanoparticle and Submicron Nanocompounds Gateway into the Cell
Dario Manzanares et al.
PHARMACEUTICS (2020)
Stress-Induced Mouse Model of the Cardiac Manifestations of Friedreich's Ataxia Corrected by AAV-mediated Gene Therapy
Christiana O. Salami et al.
HUMAN GENE THERAPY (2020)
Potential Toxicity of Iron Oxide Magnetic Nanoparticles: A Review
Nemi Malhotra et al.
MOLECULES (2020)
Chiral gold nanoparticles enantioselectively rescue memory deficits in a mouse model of Alzheimer's disease
Ke Hou et al.
NATURE COMMUNICATIONS (2020)
Effect of Physico-Chemical Properties of Nanoparticles on Their Intracellular Uptake
Parinaz Sabourian et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Particle-mediated delivery of frataxin plasmid to a human sensory neuronal model of Friedreich's ataxia
Ewa Czuba-Wojnilowicz et al.
BIOMATERIALS SCIENCE (2020)
Exenatide induces frataxin expression and improves mitochondrial function in Friedreich ataxia
Mariana Igoillo-Esteve et al.
JCI INSIGHT (2020)
Mechanisms of selective autophagy and mitophagy: Implications for neurodegenerative diseases
Charleen T. Chu
NEUROBIOLOGY OF DISEASE (2019)
Emerging pathways to neurodegeneration: Dissecting the critical molecular mechanisms in Alzheimer's disease, Parkinson's disease
Sean Hong Tan et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
FM19G11-Loaded Gold Nanoparticles Enhance the Proliferation and Self-Renewal of Ependymal Stem Progenitor Cells Derived from ALS Mice
Stefania Marcuzzo et al.
CELLS (2019)
Chitosan and chitosan coating nanoparticles for the treatment of brain disease
Shuangwen Yu et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)
Vitamin D-binding protein-loaded PLGA nanoparticles suppress Alzheimer's disease-related pathology in 5XFAD mice
Seong Gak Jeon et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2019)
Vitamin E Loaded Naringenin Nanoemulsion via Intranasal Delivery for the Management of Oxidative Stress in a 6-OHDA Parkinson's Disease Model
Bharti Gaba et al.
BIOMED RESEARCH INTERNATIONAL (2019)
Iron homeostasis and iron-regulated ROS in cell death, senescence and human diseases
Toshitaka Nakamura et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2019)
Friedreich ataxia- pathogenesis and implications for therapies
Martin B. Delatycki et al.
NEUROBIOLOGY OF DISEASE (2019)
Mitochondria, OxPhos, and neurodegeneration: cells are not just running out of gas
Estela Area-Gomez et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Nanoemulsions and Their Potential Applications in Food Industry
Jamuna Bai Aswathanarayan et al.
FRONTIERS IN SUSTAINABLE FOOD SYSTEMS (2019)
Nanomedicine review: clinical developments in liposomal applications
Esteban Beltran-Gracia et al.
CANCER NANOTECHNOLOGY (2019)
Promoting Inter-/Intra- Cellular Process of Nanomedicine through its Physicochemical Properties Optimization
Di Chen et al.
CURRENT DRUG METABOLISM (2018)
Rapid and Complete Reversal of Sensory Ataxia by Gene Therapy in a Novel Model of Friedreich Ataxia
Francoise Piguet et al.
MOLECULAR THERAPY (2018)
Review on nanoparticles and nanostructured materials: history, sources, toxicity and regulations
Jaison Jeevanandam et al.
BEILSTEIN JOURNAL OF NANOTECHNOLOGY (2018)
Mitofusin-Dependent ER Stress Triggers Glial Dysfunction and Nervous System Degeneration in a Drosophila Model of Friedreich's Ataxia
Oliver Edenharter et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)
Incorporation of Levodopa into Biopolymer Coatings Based on Carboxylated Carbon Nanotubes for pH-Dependent Sustained Release Drug Delivery
Julia Meihua Tan et al.
NANOMATERIALS (2018)
PPARγ agonist-loaded PLGA-PEG nanocarriers as a potential treatment for Alzheimer's disease: in vitro and in vivo studies
Marcelle Silva-Abreu et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
Interdependency Between Autophagy and Synaptic Vesicle Trafficking: Implications for Dopamine Release
Fiona Limanaqi et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)
Blood-Brain Delivery Methods Using Nanotechnology
Daniel Mihai Teleanu et al.
PHARMACEUTICS (2018)
Neurodegenerative Diseases: Regenerative Mechanisms and Novel Therapeutic Approaches
Rashad Hussain et al.
BRAIN SCIENCES (2018)
Enhanced neuroprotection of anthocyanin-loaded PEG-gold nanoparticles against Aβ1-42-induced neuroinflammation and neurodegeneration via the NF-KB /JNK/GSK3β signaling pathway
Min Ju Kim et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2017)
Functional single-walled carbon nanotubes 'CAR' for targeting dopamine delivery into the brain of parkinsonian mice
Qing Guo et al.
NANOSCALE (2017)
Oxidative Stress in Neurodegenerative Diseases: From Molecular Mechanisms to Clinical Applications
Zewen Liu et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)
Design of a Molecular Hybrid of Dual Peptide Inhibitors Coupled on AuNPs for Enhanced Inhibition of Amyloid β-Protein Aggregation and Cytotoxicity
Neng Xiong et al.
SMALL (2017)
Inhibition by Multifunctional Magnetic Nanoparticles Loaded with Alpha-Synuclein RNAi Plasmid in a Parkinson's Disease Model
Shuiqin Niu et al.
THERANOSTICS (2017)
Inducible and reversible phenotypes in a novel mouse model of Friedreich's Ataxia
Vijayendran Chandran et al.
ELIFE (2017)
Polyethylenimine Nanoparticle-Mediated siRNA Delivery to Reduce α-Synuclein Expression in a Model of Parkinson's Disease
Christin Helmschrodt et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2017)
Engineered Nanoparticles with Antimicrobial Property
Veliyath Gopi Reshma et al.
CURRENT DRUG METABOLISM (2017)
Friedreich's ataxia: clinical features, pathogenesis and management
A. Cook et al.
BRITISH MEDICAL BULLETIN (2017)
Iron oxide nanoparticles may damage to the neural tissue through iron accumulation, oxidative stress, and protein aggregation
Zahra Yarjanli et al.
BMC NEUROSCIENCE (2017)
Bioadhesive micelles of D-α-tocopherol polyethylene glycol succinate 1000: Synergism of chitosan and transferrin in targeted drug delivery
Poornima Agrawal et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2017)
ImmunoPEGliposome-mediated reduction of blood and brain amyloid levels in a mouse model of Alzheimer's disease is restricted to aged animals
Lara Ordonez-Gutierrez et al.
BIOMATERIALS (2017)
Compound Heterozygous FXN Mutations and Clinical Outcome in Friedreich Ataxia
Charles A. Galea et al.
ANNALS OF NEUROLOGY (2016)
PGC-1α/ERRα-Sirt3 Pathway Regulates DAergic Neuronal Death by Directly Deacetylating SOD2 and ATP Synthase β
Xuefei Zhang et al.
ANTIOXIDANTS & REDOX SIGNALING (2016)
Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases
Claudia Saraiva et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Magnetite pollution nanoparticles in the human brain
Barbara A. Maher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Permanent excimer superstructures by supramolecular networking of metal quantum clusters
Beatriz Santiago-Gonzalez et al.
SCIENCE (2016)
Nanogels as potential nanomedicine carrier for treatment of cancer: A mini review of the state of the art
Govind Soni et al.
SAUDI PHARMACEUTICAL JOURNAL (2016)
Unraveling the neurotoxicity of titanium dioxide nanoparticles: focusing on molecular mechanisms
Bin Song et al.
BEILSTEIN JOURNAL OF NANOTECHNOLOGY (2016)
Intrathecal delivery of frataxin mRNA encapsulated in lipid nanoparticles to dorsal root ganglia as a potential therapeutic for Friedreich's ataxia
Joseph F. Nabhan et al.
SCIENTIFIC REPORTS (2016)
Repeated intraperitoneal injections of liposomes containing phosphatidic acid and cardiolipin reduce amyloid-β levels in APP/PS1 transgenic mice
Lara Ordonez-Gutierrez et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2015)
Polymerized nano-curcumin attenuates neurological symptoms in EAE model of multiple sclerosis through down regulation of inflammatory and oxidative processes and enhancing neuroprotection and myelin repair
Maryam Mohajeri et al.
NEUROPHARMACOLOGY (2015)
Advances and Challenges of Liposome Assisted Drug Delivery
Lisa Sercombe et al.
FRONTIERS IN PHARMACOLOGY (2015)
Cerium oxide nanoparticles protect against Aβ-induced mitochondrial fragmentation and neuronal cell death
J. M. Dowding et al.
CELL DEATH AND DIFFERENTIATION (2014)
Effects of sub-acute exposure to TiO2, ZnO and Al2O3 nanoparticles on oxidative stress and histological changes in mouse liver and brain
Rupal Shrivastava et al.
DRUG AND CHEMICAL TOXICOLOGY (2014)
Intranasal nanoparticles of basic fibroblast growth factor for brain delivery to treat Alzheimer's disease
Chi Zhang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2014)
Single-Walled Carbon Nanotubes Alleviate Autophagic/Lysosomal Defects in Primary Glia from a Mouse Model of Alzheimer's Disease
Xue Xue et al.
NANO LETTERS (2014)
Vitamin E loaded resveratrol nanoemulsion for brain targeting for the treatment of Parkinson's disease by reducing oxidative stress
Rudra Pangeni et al.
NANOTECHNOLOGY (2014)
Polymeric micelles as drug delivery vehicles
Zaheer Ahmad et al.
RSC ADVANCES (2014)
Dendrimers: synthesis, applications, and properties
Elham Abbasi et al.
NANOSCALE RESEARCH LETTERS (2014)
Inflammation-Induced Alteration of Astrocyte Mitochondrial Dynamics Requires Autophagy for Mitochondrial Network Maintenance
Elisa Motori et al.
CELL METABOLISM (2013)
Nicotine-encapsulated poly(lactic-co-glycolic) acid nanoparticles improve neuroprotective efficacy against MPTP-induced parkinsonism
Manindra Nath Tiwari et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Mitochondrial pathophysiology in Friedreich's ataxia
Pilar Gonzalez-Cabo et al.
JOURNAL OF NEUROCHEMISTRY (2013)
Drug Delivery across the Blood-Brain Barrier
Leslie A. Khawli et al.
MOLECULAR PHARMACEUTICS (2013)
Age-dependent effects of microglial inhibition in vivo on Alzheimer's disease neuropathology using bioactive-conjugated iron oxide nanoparticles
Micaela Glat et al.
JOURNAL OF NANOBIOTECHNOLOGY (2013)
Latrepirdine: molecular mechanisms underlying potential therapeutic roles in Alzheimer’s and other neurodegenerative diseases
P R Bharadwaj et al.
Translational Psychiatry (2013)
Phototoxicity and Environmental Transformation of Polycyclic Aromatic Hydrocarbons (PAHs)-Light-Induced Reactive Oxygen Species, Lipid Peroxidation, and DNA Damage
Peter P. Fu et al.
JOURNAL OF ENVIRONMENTAL SCIENCE AND HEALTH PART C-ENVIRONMENTAL CARCINOGENESIS & ECOTOXICOLOGY REVIEWS (2012)
Control of autophagy as a therapy for neurodegenerative disease
Harry Harris et al.
NATURE REVIEWS NEUROLOGY (2012)
DJ-1 acts in parallel to the PINK1/parkin pathway to control mitochondrial function and autophagy
Kelly Jean Thomas et al.
HUMAN MOLECULAR GENETICS (2011)
Friedreich's ataxia: Pathology, pathogenesis, and molecular genetics
Arnulf H. Koeppen
JOURNAL OF THE NEUROLOGICAL SCIENCES (2011)
Toxicological considerations of clinically applicable nanoparticles
Lara Yildirimer et al.
NANO TODAY (2011)
Friedreich Ataxia: Molecular Mechanisms, Redox Considerations, and Therapeutic Opportunities
Renata Santos et al.
ANTIOXIDANTS & REDOX SIGNALING (2010)
Hypoxia-induced autophagy: cell death or cell survival?
Nathalie M. Mazure et al.
CURRENT OPINION IN CELL BIOLOGY (2010)
Nanoparticle-induced pulmonary toxicity
Jasmine Jia'en Li et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2010)
Understanding the molecular mechanisms of Friedreich's ataxia to develop therapeutic approaches
Stephane Schmucker et al.
HUMAN MOLECULAR GENETICS (2010)
Why Pleiotropic Interventions are Needed for Alzheimer's Disease
Sally A. Frautschy et al.
MOLECULAR NEUROBIOLOGY (2010)
DJ-1 is critical for mitochondrial function and rescues PINK1 loss of function
Ling-Yang Hao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Structural bases for the interaction of frataxin with the central components of iron-sulphur cluster assembly
Filippo Prischi et al.
NATURE COMMUNICATIONS (2010)
Current and emerging treatment options in the management of Friedreich ataxia
Michelangelo Michelangelo Mancuso
Neuropsychiatric Disease and Treatment (2010)
Regulation Mechanisms and Signaling Pathways of Autophagy
Congcong He et al.
ANNUAL REVIEW OF GENETICS (2009)
Loss of PINK1 Function Promotes Mitophagy through Effects on Oxidative Stress and Mitochondrial Fission
Ruben K. Dagda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
The pathogenesis of Friedreich ataxia and the structure and function of frataxin
Massimo Pandolfo et al.
JOURNAL OF NEUROLOGY (2009)
PAMAM Dendrimers as Potential Agents against Fibrillation of α-Synuclein, a Parkinson's Disease-Related Protein
Agata Rekas et al.
MACROMOLECULAR BIOSCIENCE (2009)
Role for nanomaterial-autophagy interaction in neurodegenerative disease
Stephan T. Stern et al.
AUTOPHAGY (2008)
Twenty-eight-day oral toxicity, genotoxicity, and gender-related tissue distribution of silver nanoparticles in Sprague-Dawley rats
Yong Soon Kim et al.
INHALATION TOXICOLOGY (2008)
Magnetic Iron Oxide Nanoparticles: Synthesis and Surface Functionalization Strategies
Wei Wu et al.
NANOSCALE RESEARCH LETTERS (2008)
Novel targets for Huntington's disease in an mTOR-independent autophagy pathway
Andrea Williams et al.
NATURE CHEMICAL BIOLOGY (2008)
Opinion - Pathologically activated therapeutics for neuroprotection
Stuart A. Lipton
NATURE REVIEWS NEUROSCIENCE (2007)
Free radicals, metals and antioxidants in oxidative stress-induced cancer
M Valko et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2006)
Influence of heparin and dendrimers on the aggregation of two amyloid peptides related to Alzheimer's and prion diseases
B Klajnert et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
High-dose beta-blocker hypertrophic cardiomyopathy therapy in a patient with Friedreich ataxia
J Kosutic et al.
PEDIATRIC CARDIOLOGY (2005)
Frataxin interacts functionally with mitochondrial electron transport chain proteins
P González-Cabo et al.
HUMAN MOLECULAR GENETICS (2005)
Oxidative protein folding in eukaryotes: mechanisms and consequences
BP Tu et al.
JOURNAL OF CELL BIOLOGY (2004)
Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease
B Ravikumar et al.
NATURE GENETICS (2004)
Neuronal Apoptosis in Neurodegenerative Diseases: From Basic Research to Clinical Application
Pawel Kermer et al.
NEURODEGENERATIVE DISEASES (2004)
Mechanisms of disease: Apoptosis and caspases in neurodegenerative diseases
RM Friedlander
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Brain to plasma amyloid-β efflux:: a measure of brain amyloid burden in a mouse model of Alzheimer's disease
RB DeMattos et al.
SCIENCE (2002)
Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease
RB DeMattos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)